| Announce Date | 10/23/2025 | 
| EPS Normalized Actual | $2.41 (Beat by $0.01) | 
| EPS GAAP Actual | $2.41 (Beat by $0.01) | 
| Revenue Actual | $21.957B | 
| Revenue Surprise | Beat by $21957M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $2.83157 | 
| EPS GAAP Estimate | $2.83157 | 
| Revenue Estimate | $20.299333333B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 19.1739 | 10.6 | 18.75627 | 19.80271 | 3 | 
| Dec 2028 | 16.79 | 12.11 | 16.38047 | 17.25551 | 7 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.42 | -0.34143 | 21.957B | 96.81% | 1878.33M | 
| FQ2 2025 (Jun 2025) | 2.84 | 0.074 | 21.132B | 6.44% | 849.89M | 
| FQ1 2025 (Mar 2025) | 2.59 | 2.59 | 20.886B | 6.19% | 20886M | 
| FQ4 2024 (Dec 2024) | 2.55 | 2.55 | 21.872B | 6.37% | 21872M | 
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 0.701B | -2646.36% | 701M | 
| FQ2 2024 (Jun 2024) | 2.5 | 2.5 | 19.772B | 2.91% | 19772M | 
| FQ1 2024 (Mar 2024) | 0 | 0 | 19.594B | -0.19% | 19594M | 
| FQ4 2023 (Dec 2023) | 1.74 | 1.74 | 20.478B | 1% | 20478M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.83157
Consensus Revenue Estimates
20.299333333B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.275 | -- | 3.21563 | 3.39562 | 13 | 
| FQ3 2027 (Sep 2027) | 3.56 | -- | 3.45762 | 3.64373 | 6 | 
| FQ2 2027 (Jun 2027) | 3.44 | -- | 3.34107 | 3.52091 | 6 | 
| FQ1 2027 (Mar 2027) | 3.36 | -- | 3.29909 | 3.48375 | 9 | 
| FQ4 2026 (Oct 2026) | 3.07 | -- | 2.98806 | 3.14854 | 9 | 
| FQ3 2026 (Jul 2026) | 3.06 | 20.92 | 2.97832 | 3.13828 | 9 | 
| FQ2 2026 (Jun 2026) | 3.48 | 18.39 | 3.39236 | 3.58007 | 4 | 
| FQ1 2026 (Mar 2026) | 2.9 | 10.69 | 2.82697 | 2.98339 | 4 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 25.47B | -- | 25.11B | 26.19B | 9 | 
| FQ3 2027 (Sep 2027) | 23.21B | -- | 22.69B | 23.63B | 11 | 
| FQ2 2027 (Jun 2027) | 22.75B | -- | 22.24B | 23.16B | 8 | 
| FQ1 2027 (Mar 2027) | 23.03B | -- | 22.71B | 23.68B | 9 | 
| FQ4 2026 (Oct 2026) | 20.51B | -- | 20.09B | 20.91B | 8 | 
| FQ3 2026 (Jul 2026) | 20.36B | -7.83 | 19.94B | 20.76B | 5 | 
| FQ2 2026 (Jun 2026) | 23.95B | 11.75 | 23.48B | 24.47B | 5 | 
| FQ1 2026 (Mar 2026) | 24.63B | 15.2 | 24.15B | 25.17B | 5 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.76143 | 2.42 | -0.34143 | -14.11% | 
| FQ2 2025 (Jun 2025) | 2.766 | 2.84 | 0.074 | 2.61% | 
| FQ1 2025 (Mar 2025) | 2.59 | 2.59 | 100% | |
| FQ4 2024 (Dec 2024) | 2.55 | 2.55 | 100% | |
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 100% | |
| FQ2 2024 (Jun 2024) | 2.5 | 2.5 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 1.74 | 1.74 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $20.08B | $21.96B | $1878.33M | 8.55% | 
| FQ2 2025 (Jun 2025) | $20.28B | $21.13B | $849.89M | 4.02% | 
| FQ1 2025 (Mar 2025) | $0B | $20.89B | $20886M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $21.87B | $21872M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.7B | $701M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $19.77B | $19772M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $19.59B | $19594M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $20.48B | $20478M | 100% |